The Telegraph
Since 1st March, 1999
Steel firms on cutting edge
SAIL, Essar, Ispat and Jindal today slashed steel prices by Rs 500-1,000 a tonne on all grades. ...  | Read.. 
Margins seen under pressure
The reduction in prices is likely to hit the bottomlines of all steel firms, although the impact on those lacking vertically ...  | Read.. 
Reductions drag down markets
Steel stocks tanked 2-8 per cent on the bourses today on fears that price cuts will hit their bottomlines. ...  | Read.. 
Tisco prices frozen till March
As other steelmakers answered Ratan Tata’s weekend call to drop prices, Tata Steel went a step ahead to declare that it woul ...  | Read.. 
Trai wings clipped on link-up rows
In a major setback to the Telecom Regulatory Authority of India (Trai), the Telecom Dispute Settlement and Appellate Tribuna ...  | Read.. 
Steel firms on cutting edge
Hindalco-Indal merger plan okayed
The boards of two Aditya Birla group companies — Hindalco and Indal — today approved a scheme of ar..  | Read.. 
S&P boosts forex rating outlook
Global rating agency Standard & Poor's (S&P) today revised its outlook on India's..  | Read.. 
Citigroup raises offer price for e-Serve
Citigroup has raised the offer price for e-Serve International Ltd, an IT-enabled services company,..  | Read.. 
Bosch revs up, to invest Rs 1000 cr
Motor Industries Co Ltd (MICO), the Indian arm of the Germany-based Bosch group, today said it ..  | Read.. 
Crystal clear policy on bank merger
With the stage set for consolidation of the banking sector, the UPA government has asked the In..  | Read.. 
E-governance put on fast track
The parliamentary standing committee on information technology (IT) has asked the government t..  | Read.. 
More funds for rural phones
The department of telecommunications (DoT) should seek higher allocation for the Universal Serv..  | Read.. 
Clamour for cheap tea loans
The Tea Board has urged the government to float a special purpose vehicle for providing long-te..  | Read.. 
Drug firms eye growth in insulin market
Biocon, Eli Lily and Ranbaxy are eyeing the Rs 300-crore domestic insulin market for new produc..  | Read.. 
Mutual Funds
Glenmark clinical trials
Capital Intl
Man venture
Wipro Tech
Lodha contests claim
TCS board
Maruti prices
Ijma chief
Gail project